Mannkind (MNKD) Assets Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.66% |
| Dec 31, 2025 | 38.95% |
| Sep 30, 2025 | 18.96% |
| Jun 30, 2025 | 12.94% |
| Mar 31, 2025 | 9.98% |
| Dec 31, 2024 | 7.04% |
| Sep 30, 2024 | 24.91% |
| Jun 30, 2024 | 20.64% |
| Mar 31, 2024 | 14.62% |
| Dec 31, 2023 | 63.56% |
| Sep 30, 2023 | 49.60% |
| Jun 30, 2023 | 45.01% |
| Mar 31, 2023 | 54.90% |
| Dec 31, 2022 | 46.60% |
| Sep 30, 2022 | 45.63% |
| Jun 30, 2022 | 51.74% |
| Mar 31, 2022 | 45.08% |
| Dec 31, 2021 | 43.93% |
| Sep 30, 2021 | 73.82% |
| Jun 30, 2021 | 59.62% |
| Mar 31, 2021 | 72.82% |
| Dec 31, 2020 | 8.69% |
| Sep 30, 2020 | 19.21% |
| Jun 30, 2020 | 9.00% |
| Mar 31, 2020 | -1.99% |
| Dec 31, 2019 | -4.34% |
| Sep 30, 2019 | -0.34% |
| Jun 30, 2019 | -16.29% |
| Mar 31, 2019 | 2.68% |
| Dec 31, 2018 | -5.20% |
| Sep 30, 2018 | -45.36% |
| Jun 30, 2018 | -43.93% |
| Mar 31, 2018 | -44.40% |
| Dec 31, 2017 | -40.15% |
| Sep 30, 2017 | -47.34% |
| Jun 30, 2017 | -30.49% |
| Mar 31, 2017 | -27.61% |
| Dec 31, 2016 | -25.47% |
| Sep 30, 2016 | -30.60% |
| Jun 30, 2016 | -13.09% |
| Mar 31, 2016 | -24.32% |
| Dec 31, 2015 | -20.47% |
| Sep 30, 2015 | 9.75% |
| Jun 30, 2015 | 13.61% |
| Mar 31, 2015 | 12.71% |
| Dec 31, 2014 | 25.50% |
| Sep 30, 2014 | 19.97% |
| Jun 30, 2014 | 1.15% |
| Dec 31, 2013 | -2.29% |